Moreover, in Hu’s study [30], it was shown that Wnt antagonists WIF1-Fc and SFRP1-Fc inhibit Wnt signalling and exert antitumour activity by inducing apoptosis in tumour cells, which indicates that Wnt antagonists would be a promising molecular treatment for HCC. This evidence concerns the gene SFRP1 and hepatocellular carcinoma.